Jim Cramer advises investors to buy, not sell, after Tuesday’s sale

After a tough day of trading on Wall Street, CNBC’s Jim Cramer said the market gives investors the opportunity to find stocks that are great buys.

“Even though we had a brutal sell today, we are still in one of the biggest second chance markets I have ever seen, as you have seen with the manufacturers between mid-morning and the end of the day, “the” Mad Money, “the host said.

Stocks had a mixed session on Tuesday, with the Dow Jones gaining at the close and the S&P 500 falling 0.7%. The highly technological Nasdaq Composite fell nearly 2%.

“We’ve seen this happen countless times, folks, but it’s very hard for people to remember that you’re supposed to buy, not sell, when stocks are crashing,” Cramer said.

Cramer pointed to trading drug stocks to argue against the sale in the face of a liquidation. Shares of Merck, Bristol-Myers Squibb and Eli Lilly, he noted, rebounded after missing estimates in their quarterly earnings reports last week.

“I think Eli Lilly, which we own for the charitable trust… represents real value compared to the rest of the market,” he said. “Lilly makes her fortune and when her stock got smashed on a bad tape you have to buy her. Apparently a lot of fund managers agree because she ended up rallying today.”

Eli Lilly stock closed at $ 188.20 on Tuesday after rising 1.2%. Cramer suggested that Eli Lilly’s decision on Monday to authorize a $ 5 billion buyout could be a turning point for the stock, which is down more than 11% from the end of January.

READ  Warren Buffett says Robinhood responds to investors' gaming instincts

Disclosure: Cramer Charitable Trust owns shares of Eli Lilly.

Warning

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to dive deep into the world of Cramer? Hit him!
Crazy Money TwitterJim Cramer on TwitterFacebookInstagram

Questions, comments, suggestions for the “Mad Money” site? madcap@cnbc.com

Leave a Reply

Your email address will not be published. Required fields are marked *